Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial



      Duodenojejunal bypass with sleeve gastrectomy (DJB-SG) is a novel bariatric surgery composed of sleeve gastrectomy (SG) and duodenojejunal anastomosis. Both loop and Roux-en-Y DJB-SGs were reported to have acceptable hypoglycemic and weight loss outcomes, but it remains unclear which reconstruction method is better regarding therapeutic efficacy and safety for type 2 diabetes (T2D).


      This study was undertaken to prospectively compare the short-term therapeutic outcomes and surgical safety of loop versus Roux-en-Y DJB-SG.


      University hospital.


      A total of 96 patients with T2D with body mass index of 27.5–40 kg/m2 were randomized in a 1:1 ratio to undergo loop or Roux-en-Y DJB-SG from January 2020 to December 2020. The primary end point was to determine the 1-year T2D remission rate. Additionally, medical cost, operative outcomes, weight loss, metabolic improvement, nutritional status, and gastrointestinal disorders at 1-year follow-up also were determined.


      The preoperative data were comparable at baseline. The 1-year follow-up rate was 89.6% (43 of 48 patients) for loop DJB-SG and 93.8% (45 of 48 patients) for Roux-en-Y DJB-SG. The T2D remission rates were 93.02% (40 of 43) for loop DJB-SG and 88.89% (40 of 45) for Roux-en-Y DJB-SG at 1-year follow-up. Loop DJB-SG patients exhibited higher total weight loss (30.85% ± 7.24% versus 26.11% ± 7.12%), shorter operative times, and less medical cost than Roux-en-Y DJB-SG patients. However, there was no statistical difference regarding lipid profiles, major postoperative complications, nutritional status, and gastrointestinal disorders between the 2 groups.


      Despite similar hypoglycemic effects, loop DJB-SG was simpler and exhibited better weight loss and less medical cost than Roux-en-Y DJB-SG. Thus, loop DJB-SG was better than Roux-en-Y DJB-SG for T2D.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wang L.
        • Peng W.
        • Zhao Z.
        • et al.
        Prevalence and treatment of diabetes in China, 2013–2018.
        JAMA. 2021; 326: 2498-2506
        • Rubino F.
        • Nathan D.M.
        • Eckel R.H.
        • et al.
        Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations.
        Diabetes Care. 2016; 39: 861-877
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwan J.P.
        • et al.
        Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes.
        N Engl J Med. 2017; 376: 641-651
        • Carlsson L.M.S.
        • Sjoholm K.
        • Jacobson P.
        • et al.
        Life expectancy after bariatric surgery in the Swedish Obese Subjects Study.
        N Engl J Med. 2020; 383: 1535-1543
        • Yu J.
        • Zhou X.
        • Li L.
        • et al.
        The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence.
        Obes Surg. 2015; 25: 143-158
        • Strain G.W.
        • Torghabeh M.H.
        • Gagner M.
        • et al.
        Nutrient status 9 years after biliopancreatic diversion with duodenal switch (BPD/DS): an observational study.
        Obes Surg. 2017; 27: 1709-1718
        • Potoczna N.
        • Harfmann S.
        • Steffen R.
        • et al.
        Bowel habits after bariatric surgery.
        Obes Surg. 2008; 18: 1287-1296
        • Angrisani L.
        • Santonicola A.
        • Iovino P.
        • et al.
        Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014.
        Obes Surg. 2017; 27: 2279-2289
        • Huang C.K.
        • Goel R.
        • Tai C.M.
        • et al.
        Novel metabolic surgery for type II diabetes mellitus: loop duodenojejunal bypass with sleeve gastrectomy.
        Surg Laparosc Endosc Percutan Tech. 2013; 23: 481-485
        • Kasama K.
        • Tagaya N.
        • Kanehira E.
        • et al.
        Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results.
        Obes Surg. 2009; 19: 1341-1345
        • Lee W.J.
        • Almulaifi A.M.
        • Tsou J.J.
        • et al.
        Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion.
        Surg Obes Relat Dis. 2015; 11: 765-770
        • Huang C.K.
        • Tai C.M.
        • Chang P.C.
        • et al.
        Loop duodenojejunal bypass with sleeve gastrectomy: comparative study with Roux-en-Y gastric bypass in type 2 diabetic patients with a BMI <35 kg/m2: first year results.
        Obes Surg. 2016; 26: 2291-2301
        • Lee W.J.
        • Lee K.T.
        • Kasama K.
        • et al.
        Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): short-term result and comparison with gastric bypass.
        Obes Surg. 2014; 24: 109-113
        • Seki Y.
        • Kasama K.
        • Haruta H.
        • et al.
        Five-year-results of laparoscopic sleeve gastrectomy with duodenojejunal bypass for weight loss and type 2 diabetes mellitus.
        Obes Surg. 2017; 27: 795-801
        • Seki Y.
        • Kasama K.
        • Yasuda K.
        • et al.
        The effects of laparoscopic sleeve gastrectomy with duodenojejunal bypass on Japanese patients with BMI <35 kg/m2 on type 2 diabetes mellitus and the prediction of successful glycemic control.
        Obes Surg. 2018; 28: 2429-2438
        • Lin S.
        • Li C.
        • Guan W.
        • Liang H.
        Can staple-line reinforcement eliminate the major early postoperative complications after sleeve gastrectomy?.
        Asian J Surg. 2021; 44: 836-840
        • Riddle M.C.
        • Cefalu W.T.
        • Evans P.H.
        • et al.
        Consensus report: definition and interpretation of remission in type 2 diabetes.
        Diabetes Care. 2021; 44: 2438-2444
        • Buse J.B.
        • Caprio S.
        • Cefalu W.T.
        • et al.
        How do we define cure of diabetes?.
        Diabetes Care. 2009; 32: 2133-2135
        • Ren Z.Q.
        • Zhang P.B.
        • Zhang X.Z.
        • et al.
        Duodenal-jejunal exclusion improves insulin resistance in type 2 diabetic rats by upregulating the hepatic insulin signaling pathway.
        Nutrition. 2015; 31: 733-739
        • Kashihara H.
        • Shimada M.
        • Kurita N.
        • et al.
        Duodenal-jejunal bypass improves insulin resistance by enhanced glucagon-like peptide-1 secretion through increase of bile acids.
        Hepatogastroenterology. 2014; 61: 1049-1054
        • Eskandaros M.S.
        • Abbass A.
        Standard biliopancreatic limb (50 cm) Roux-en-Y gastric bypass versus long biliopancreatic limb (100 cm) Roux-en-Y gastric bypass in patients with body mass index 40–50 kg/m2: a randomized prospective study.
        Obes Surg. 2022; 32: 577-586
        • Zerrweck C.
        • Herrera A.
        • Sepulveda E.M.
        • Rodriguez F.M.
        • Guilbert L.
        Long versus short biliopancreatic limb in Roux-en-Y gastric bypass: short-term results of a randomized clinical trial.
        Surg Obes Relat Dis. 2021; 17: 1425-1430
        • Tasdighi E.
        • Barzin M.
        • Mahawar K.K.
        • et al.
        Effect of biliopancreatic limb length on weight loss, postoperative complications, and remission of comorbidities in one anastomosis gastric bypass: a systematic review and meta-analysis.
        Obes Surg. 2022; 32: 892-903
        • Lin S.
        • Yang N.
        • Guan W.
        • Liang H.
        Can Chinese T2D patients with BMI 20–32.5 kg/m2 benefit from loop duodenojejunal bypass with sleeve gastrectomy?.
        Surg Obes Relat Dis. 2019; 15: 1513-1519
        • Cottam A.
        • Cottam D.
        • Portenier D.
        • et al.
        A matched cohort analysis of stomach intestinal pylorus saving (SIPS) surgery versus biliopancreatic diversion with duodenal switch with two-year follow-up.
        Obes Surg. 2017; 27: 454-461
        • Finno P.
        • Osorio J.
        • Garcia-Ruiz-de-Gordejuela A.
        • et al.
        Single versus double-anastomosis duodenal switch: single-site comparative cohort study in 440 consecutive patients.
        Obes Surg. 2020; 30: 3309-3316
        • Iranmanesh P.
        • Boudreau V.
        • Barlow K.
        • et al.
        Comparison of single- versus double-anastomosis duodenal switch: a single-center experience with 2-year follow-up.
        Int J Obes (Lond). 2021; 45: 1782-1789
        • Malo F.C.
        • Marion A.
        • Rioux A.
        • et al.
        Long alimentary limb duodenal switch (LADS): an exploratory randomized trial, results at 2 years.
        Obes Surg. 2020; 30: 5047-5058
        • Felsenreich D.M.
        • Langer F.B.
        • Eichelter J.
        • et al.
        Bariatric surgery: how much malabsorption do we need? A review of various limb lengths in different gastric bypass procedures.
        J Clin Med. 2021; 10: 674
        • Yeo C.
        • Kaushal S.
        • Lim B.
        • et al.
        Impact of bariatric surgery on serum uric acid levels and the incidence of gout: a meta-analysis.
        Obes Rev. 2019; 20: 1759-1770
        • Li C.
        • Lin S.
        • Liang H.
        Single-anastomosis duodenal switch: conceptual difference between East and West.
        Obes Surg. 2021; 31: 3296-3302
        • Surve A.
        • Cottam D.
        • Sanchez-Pernaute A.
        • et al.
        The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience.
        Surg Obes Relat Dis. 2018; 14: 594-601
        • Johansson K.
        • Svensson P.A.
        • Soderling J.
        • et al.
        Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study.
        Lancet Diabetes Endocrinol. 2021; 9: 515-524
        • Mion F.
        • Tolone S.
        • Garros A.
        • et al.
        High-resolution impedance manometry after sleeve gastrectomy: increased intragastric pressure and reflux are frequent events.
        Obes Surg. 2016; 26: 2449-2456
        • Bevilacqua L.A.
        • Obeid N.R.
        • Yang J.
        • et al.
        Incidence of GERD, esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma after bariatric surgery.
        Surg Obes Relat Dis. 2020; 16: 1828-1836
        • Qumseya B.J.
        • Qumsiyeh Y.
        • Ponniah S.A.
        • et al.
        Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis.
        Gastrointest Endosc. 2021; 93 (52.e2): 343